Retatrutide — lab test, October 2026
COA A60-556 matches Uzorak's public record. So this test doesn't rest on our review alone — the lab confirms it too.
A60-556Test results
Not on file for this certificate: sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 60 mg · Lab measured 54.13 mg
90% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 13.5 mg using the measured mass, against 15 mg on the label — 10% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | A60-556 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Uzorak's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by Uzorak on October 16, 2026. Reported purity: 99.74%. Net content: 54.13 mg against 60 mg labeled (90% of label). Endotoxins: Under 10 EU / Vial (assay range 10-1000 EU/Vial). Batch rt60. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion